Evidence map›Paper›PMID 36834877›Full record

ArticleInternational journal of molecular sciences2023

Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent.

Giovanni Reale, Francesca Calderoni, Teresa Ghirardi, Francesca Porto, Federica Illuminati, Lorenza Marvelli, Petra Martini, Licia Uccelli, Eugenia Tonini, Lucia Del Bianco and 8 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mn-Based MRI Contrast Agents: An Overview.Molecules (Basel, Switzerland) · 2023
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Giovanni RealeDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-7241-7006
Francesca CalderoniMedical Physics Unit, University Hospital of Ferrara, 44124 Cona, Italy.
Teresa GhirardiLegnaro National Laboratories (LNL-INFN), National Institute of Nuclear Physics, 35020 Padua, Italy.ORCID 0000-0002-1135-1899
Francesca PortoDepartment of Chemical, Pharmaceutical and Agricultural Sciences , University of Ferrara, 44121 Ferrara, Italy.
Federica IlluminatiRadiology Unit, University Hospital of Ferrara, 44124 Cona, Italy.
Lorenza MarvelliDepartment of Chemical, Pharmaceutical and Agricultural Sciences , University of Ferrara, 44121 Ferrara, Italy.
Petra MartiniDepartment of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-4059-4814
Licia UccelliDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-1490-0718
Eugenia ToniniMedical Physics Unit, University Hospital of Ferrara, 44124 Cona, Italy.ORCID 0000-0002-7577-5201
Lucia Del BiancoDepartment of Physics and Earth Science, University of Ferrara, 44122 Ferrara, Italy.ORCID 0000-0002-3110-7287
Federico SpizzoDepartment of Physics and Earth Science, University of Ferrara, 44122 Ferrara, Italy.ORCID 0000-0002-9134-4487
Martina CapozzaDepartment of Molecular Biotechnologies and Health Sciences, University of Torino, 10126 Torino, Italy.ORCID 0000-0001-9125-8004
Emiliano CazzolaIRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella (VR), 37024 Negrar, Italy.ORCID 0000-0002-2606-9327
Aldo CarnevaleDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-8191-6042
Melchiore GigantiDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Alessandro TurraMedical Physics Unit, University Hospital of Ferrara, 44124 Cona, Italy.
Juan EspositoLegnaro National Laboratories (LNL-INFN), National Institute of Nuclear Physics, 35020 Padua, Italy.ORCID 0000-0002-6443-7039
Alessandra BoschiDepartment of Chemical, Pharmaceutical and Agricultural Sciences , University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-6382-1944

Funding

Legnaro National Laboratories CSN5University of Ferrara FIR2020, FAR2021, FAR2022, FIRD2022
6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) is a non-invasive powerful modern clinical technique that is extensively used for the high-resolution imaging of soft tissues. To obtain high-definition pictures of tissues or of the whole organism this technique is enhanced by the use of contrast agents. Gadolinium-based contrast agents have an excellent safety profile. However, over the last two decades, some specific concerns have surfaced. Mn(II) has different favorable physicochemical characteristics and a good toxicity profile, which makes it a good alternative to the Gd(III)-based MRI contrast agents currently used in clinics. Mn(II)-disubstituted symmetrical complexes containing dithiocarbamates ligands were prepared under a nitrogen atmosphere. The magnetic measurements on Mn complexes were carried out with MRI phantom measurements at 1.5 T with a clinical magnetic resonance. Relaxivity values, contrast, and stability were evaluated by appropriate sequences. Studies conducted to evaluate the properties of paramagnetic imaging in water using a clinical magnetic resonance showed that the contrast, produced by the complex [Mn(II)(L')

Indexed as

Contrast MediaManganeseGadoliniumMagnetic Resonance ImagingMagnetic Resonance SpectroscopyContrast MediaGadoliniumManganesedithiocarbamatesmagnetic resonance imagingmanganese

Identifiers

PMID36834877
PMCPMC9965609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.